Among commonly used antiplatelet agents, prasugrel offers the most optimal balance between efficacy and safety after invasive management of patients with coronary syndrome, a meta-analysis finds.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/prasugrel-outshines-rival-drugs-after-invasive-coronary-care-2026a1000i8y?src=rss
Author :
Publish date : 2026-06-02 05:30:00
Copyright for syndicated content belongs to the linked Source.